HCA — HCA Healthcare Inc
NYSE · Health Care · Health Care
- Latest Close
- $474.03
- 30-Day Move
- +0.5%
- Market Cap
- $105.5B
- Shares Outstanding
- 223,570,000
- P/E Ratio
- 15.55
- P/B Ratio
- 97.29
Analyst consensus: Buy · 31 analysts
HCA Healthcare Inc
A read-only Alphactor snapshot forHCA Healthcare Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-23
Topline snapshot
Latest Close
$474.03
30-Day Move
+0.5%
Market Cap
$105.5B
Shares Outstanding
223,570,000
P/E Ratio
15.55
P/B Ratio
97.29
$474.03
+0.5%last 90 delayed daily bars
90D High
$556.52
90D Low
$459.22
Avg Volume
1,074,554
Gross margin is running at 85.0%, which gives a quick read on operating quality before you open the full model.
Net margin is 9.0%, useful for comparing HCA against peers in Health Care.
HCA is up 0.5% over the last 30 trading days shown on this page.
Latest operating income is $3.2B, which helps anchor the headline ratios with an actual earnings figure.
Composite Fair Value
$735.16
Rule of 40
17.3%
Latest Close
$474.03
30-Day Move
+0.5%
Market Cap
$105.5B
Shares Outstanding
223,570,000
P/E Ratio
15.55
P/B Ratio
97.29
ROE
656.3%
ROA
11.2%
Gross Margin
85.0%
Operating Margin
15.8%
Net Margin
9.0%
Debt / Equity
54.2
Current Ratio
0.97
Dividend Yield
66.1%
Latest Revenue
$19.5B
Revenue
$19.5B
Gross Profit
$8.2B
Operating Income
$3.2B
Net Income
$1.9B
Gross Margin
8496.0%
Net Margin
897.0%
Current Ratio
0.97
Debt / Equity
54.20
Fair Value
$735.16
Upside / Downside
+55.1%
Signal
Undervalued
Implied Growth
5.4%
DCF
$470.37
EPV
$257.54
EV/Rev
$1477.58
Growth Assumption
7.9%
Discount Rate
8.6%
Terminal Growth
2.0%
Base FCF
$7.7B
Valuation spread
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Low growth priced in
Altman Z
2.75
Grey
Piotroski
7
Strong (7-9)
Cash Conversion
1.86x
Rule of 40
17.3%
Concerning
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $60.2B | $9.1B | $5.6B | $4.1B |
| 2023-12-31 | $65.0B | $9.6B | $5.2B | $4.7B |
| 2024-12-31 | $70.6B | $10.5B | $5.8B | $5.6B |
| 2025-12-31 | $75.6B | $12.0B | $6.8B | $7.7B |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
Buy Value
$0
Sell Value
$39M
Buys
0
Sells
15
Buy Value
$0
Sell Value
$39M
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-02-18 | McAlevey Michael R | Sell | 1,694 | $533.37 |
| 2026-02-13 | McAlevey Michael R | M | 5,000 | $0.00 |
| 2026-02-13 | McAlevey Michael R | F | 3,306 | $540.29 |
| 2026-02-13 | McAlevey Michael R | M | 5,000 | $236.61 |
| 2026-02-11 | Berres Jennifer | Sell | 4,010 | $526.16 |
| 2026-02-11 | Berres Jennifer | Sell | 4,010 | $503.00 |
| 2026-02-11 | Wyatt Christopher F. | Sell | 4,000 | $505.00 |
| 2026-02-10 | Rossitto Erica | F | 418 | $502.05 |
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5,018,244 | 0.02% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 4,028,271 | 0.02% | 2025-12-31 |
| GROWTH FUND OF AMERICA | 4,004,292 | 0.02% | 2025-12-31 |
| First Eagle Funds-First Eagle Global Fund | 2,480,957 | 0.01% | 2026-01-31 |
| VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund | 2,141,200 | 0.01% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 2,032,838 | 0.01% | 2026-02-28 |
| iShares Trust-iShares Core S&P 500 ETF | 2,036,148 | 0.01% | 2026-02-28 |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1,812,627 | 0.01% | 2026-03-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Scion Asset Management / Burry
Filed 2025-05-15
--
--
Two Sigma Advisers
Filed 2025-05-15
--
--
Vanguard Group
Filed 2026-01-29
$6.9B
-1.2%
BlackRock
Filed 2024-05-10
$4.9B
--
FMR LLC (Fidelity)
Filed 2026-02-17
$1.8B
+101.2%
Geode Capital Management
Filed 2026-02-09
$1.7B
+0.4%
3.74
Consensus
Buy—
—
—
31
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.